ConductScience.org, home

Paper465283

Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients.

Finch RE and 2 others. Br J Clin Pharmacol, 1979. Cited by 56 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients. Papers, record 465283. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/465283

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
2.56
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Finch RER E
2Bending MRM R
3Lant AFA F

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FluorouracilMajor topic
NeoplasmsMajor topic
Administration, Oral
Adult
Aged
Drug Therapy, Combination
Female
Humans
Injections, Intravenous
Kinetics
Male
Middle Aged

Source PubMed

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114,217,470A LESS TOXIC FLUOROURACIL DOSAGE SCHEDULE.JAMA1964https://conductscience.org/library/papers/14217470PubMed
214,070,379EXPERIMENTAL AND CLINICAL USE OF FLUORINATED PYRIMIDINES IN CANCER CHEMOTHERAPY.Cancer Res1963https://conductscience.org/library/papers/14070379PubMed
378,795Antineoplastic drugs: clinical pharmacology and therapeutic use.Drugs1978https://conductscience.org/library/papers/78795PubMed
469,319Clinical pharmacology of anticancer drugs.Semin Oncol1977https://conductscience.org/library/papers/69319PubMed
5350,471Why monitor serum levels of gentamicin?Clin Pharmacokinet1978https://conductscience.org/library/papers/350471PubMed
6336,866Kinetics and mechanisms of drug action of microorganisms XXIII: microbial kinetic assay for fluorouracil in biological fluids and its application to human pharmacokinetics.J Pharm Sci1977https://conductscience.org/library/papers/336866PubMed
7302,412Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity.N Engl J Med1977https://conductscience.org/library/papers/302412PubMed
8702,315Use of a nitrogen detector for GLC determination of fluorouracil in plasma during single- and combined-agent chemotherapy.J Pharm Sci1978https://conductscience.org/library/papers/702315PubMed
9678,346Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration.Clin Pharmacokinet1978https://conductscience.org/library/papers/678346PubMed
10666,946Plasma concentrations of isosorbide dinitrate and its metabolites after chronic high oral dosage in man.Br J Clin Pharmacol1978https://conductscience.org/library/papers/666946PubMed
11639,472Changes in absorptive and peptide hydrolase activities in rat small intestine after administration of 5-fluorouracil.Clin Sci Mol Med1978https://conductscience.org/library/papers/639472PubMed
12589,882Pharmacokinetics of 5-fluorouracil: inter-relationship with biochemical kinetics in monitoring therapy.Clin Pharmacokinet1977https://conductscience.org/library/papers/589882PubMed
134,304,025Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.Cancer1969https://conductscience.org/library/papers/4304025PubMed
144,264,5815-Fluorouracil in the treatment of gastrointestinal neoplasia.N Engl J Med1973https://conductscience.org/library/papers/4264581PubMed
154,259,631The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.Cancer Res1972https://conductscience.org/library/papers/4259631PubMed
164,609,602Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).Cancer Chemother Rep1974https://conductscience.org/library/papers/4609602PubMed
174,810,089The administration of 5-fluorouracil by mouth.Cancer1974https://conductscience.org/library/papers/4810089PubMed
181,097,091Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography.Cancer Chemother Rep1975https://conductscience.org/library/papers/1097091PubMed
191,203,840Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma.Cancer1975https://conductscience.org/library/papers/1203840PubMed
205,144,521Seventy-five cases of solid tumours treated by a modified quadruple chemotherapy regime.Br J Cancer1971https://conductscience.org/library/papers/5144521PubMed

See all 21 references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
40,430,4725-Fluorouracil Toxicity: Revisiting the Relevance of Pharmacokinetic Parameters.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40430472PubMed
26,247,632Targeted expression of BikDD combined with metronomic doxorubicin induces synergistic antitumor effect through Bax activation in hepatocellular carcinoma.Oncotarget2015https://conductscience.org/library/papers/26247632PubMed
25,317,186Effect of Skimmed Milk on the Absorption and Metabolism of5-Fluorouracil (5-FU) in Animals.Iran J Pharm Res2012https://conductscience.org/library/papers/25317186PubMed
25,301,172Radiosensitization of gliomas by intracellular generation of 5-fluorouracil potentiates prodrug activator gene therapy with a retroviral replicating vector.Cancer Gene Ther2014https://conductscience.org/library/papers/25301172PubMed
18,846,242DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY (DPD) IN GI MALIGNANCIES: EXPERIENCE OF 4-YEARS.Pak J Med Sci2007https://conductscience.org/library/papers/18846242PubMed
11,081,572Preclinical development of eniluracil: enhancing the therapeutic index and dosing convenience of 5-fluorouracil.Invest New Drugs2000https://conductscience.org/library/papers/11081572PubMed
11,081,5675-Fluorouracil: forty-plus and still ticking. A review of its preclinical and clinical development.Invest New Drugs2000https://conductscience.org/library/papers/11081567PubMed
10,958,591The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.Invest New Drugs2000https://conductscience.org/library/papers/10958591PubMed
8,248,2115-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/8248211PubMed
7,840,584In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi.Antimicrob Agents Chemother1994https://conductscience.org/library/papers/7840584PubMed
7,160,054Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7160054PubMed
6,639,0035-fluorocytosine susceptibility of pathogenic fungi in the presence of allopurinol: potential for improving the therapeutic index of 5-fluorocytosine.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6639003PubMed
6,487,480The influence of cimetidine on the pharmacokinetics of 5-fluorouracil.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487480PubMed
3,729,334Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora.Antimicrob Agents Chemother1986https://conductscience.org/library/papers/3729334PubMed
3,609,119Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patients.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/3609119PubMed
3,445,826Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.Agents Actions1987https://conductscience.org/library/papers/3445826PubMed
2,656,050Clinical pharmacology of 5-fluorouracil.Clin Pharmacokinet1989https://conductscience.org/library/papers/2656050PubMed
1,794,023Levamisole/fluorouracil. A review of their pharmacology and adjuvant therapeutic use in colorectal cancer.Drugs Aging1991https://conductscience.org/library/papers/1794023PubMed
533,583Kinetics of 5-fluorouracil.Br J Clin Pharmacol1979https://conductscience.org/library/papers/533583PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/465283

GET https://conductscience.org/api/papers/v1/465283/references?page=2